Roman Butler Fullerton & Co »

Corcept Therapeutics Incorporated shares owned by Roman Butler Fullerton & Co

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Roman Butler Fullerton & Co from 13F filings

Historical chart of Roman Butler Fullerton & Co investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Roman Butler Fullerton & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Roman Butler Fullerton & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $207k 9.3k 22.30

More positions owned by Roman Butler Fullerton & Co

Microsoft Corporation (MSFT)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Vanguard Specialized Funds Div App Etf (VIG)
Meta Platforms Cl A (META)
Cigna Corp (CI)
Alphabet Cap Stk Cl C (GOOG)
Proshares Tr S&p 500 Dv Arist (NOBL)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Procter & Gamble Company (PG)
Wal-Mart Stores (WMT)

View all positions for Roman Butler Fullerton & Co

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Geode Capital Management
First Trust Advisors
Btim
Federated Investors
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Man Group
Susquehanna International
Ikarian Capital
Millennium Management

View all funds holding Corcept Therapeutics Incorporated